Ph.D. in Experimental Therapeutics
About the Program
Experimental therapeutics focuses on the study of and development of new treatments for human disease. Research in experimental therapeutics seeks to understand human diseases from the molecular level to the whole organism in order to develop rational approaches for new pharmacological treatments. In addition, experimental therapeutics includes the development of new therapies through systematic investigation at increasing levels of complexity ranging from individual molecules and proteins, to cellular and tissue based assays and to the whole organism. This program trains students at the doctoral level so that you can translate discoveries in the laboratory to therapies in a clinical setting.
About the Curriculum
The curriculum for the Experimental Therapeutics Ph.D. program includes required courses, electives, and a dissertation. Satisfactory overall performance is expected on a written qualifying examination, administered before starting the dissertation research. A grade of B- or higher is expected to be maintained for the required courses. A grade of B- or higher is also required for all of the prerequisite and co-requisite courses. An overall GPA of 3.0 or higher must be maintained.
Funding
Funding for graduate students is limited, and when available, it is offered to applicants based on strengths of their credentials compared with the others in the same pool of applications. It is accomplished in one of three (3) ways:
- Teaching Assistantships include a waiver of tuition, but not student fees, and a stipend provided by the graduate school for approximately 20 hours per week of specialized service to the College of Pharmacy and Pharmaceutical Sciences.
- Research Assistantships are offered through research grants.
- Tuition waiver only
Dual-Degree Option
Pharm.D./Ph.D. in Experimental Therapeutics
With this dual-degree option, there is some overlap and flexibility, allowing a student to complete graduate-level requirements for both degrees in four to four and a half years. In general terms, students will follow the sequence for the Pharm.D. curriculum during the first four semesters, taking one graduate-level experimental therapeutics course each semester. In the fifth semester, students will take the required Pharm.D. clerkships, plus the two- hour seminar, with at least one clerkship rotation involving a research experience. The advisor can approve 6000-level and above Pharm.D. courses as Ph.D. electives. Beginning with sixth semester (summer following the second year in the program), students will start to complete the remaining requirements for the Ph.D. in Experimental Therapeutics.
Meet Angelique Nyinawabera Khalifa, Ph.D.
'19, Ph.D. in Experimental Therapeutics
"Dr. Tiwari's mentorship and guidance prepared me for the real world. As I continue to navigate the professional world, I always go back to him for more advice. I find it so fulfilling to know that my work is contributing to many people's better quality of life."
CONTACT US
